In conclusion, these results demonstrated that antigen-containing mitochondria (OVA-MITO and TRP2-MITO) exhibited potent Antitumor efficacy as prophylactic and therapeutic cancer treatment vaccines. The gene discussed is DCT; the disease is cancer.